pI: 7.769 |
Length (AA): 561 |
MW (Da): 64535 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
31 | 86 | 1d4d (A) | 108 | 163 | 29.00 | 0 | 0.21 | 0.244522 | 1.36 |
48 | 556 | 1onf (A) | 1 | 494 | 84.00 | 0 | 1 | 1.66911 | 0.09 |
238 | 374 | 2ywl (A) | 2 | 144 | 15.00 | 0 | 0.93 | 0.376907 | -0.6 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126785)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G54660 | glutathione reductase |
Arabidopsis thaliana | AT3G24170 | glutathione-disulfide reductase |
Babesia bovis | BBOV_I002190 | thiodoxin reductase, putative |
Brugia malayi | Bm1_04825 | glutathione reductase |
Brugia malayi | Bm1_36410 | Thioredoxin reductase |
Candida albicans | CaO19.11623 | similar to S. cerevisiae GLR1 (YPL091W) glutathione oxidoreductase |
Candida albicans | CaO19.4147 | similar to S. cerevisiae GLR1 (YPL091W) glutathione oxidoreductase |
Caenorhabditis elegans | CELE_C46F11.2 | Protein GSR-1, isoform B |
Caenorhabditis elegans | CELE_ZK637.10 | Protein TRXR-2 |
Cryptosporidium hominis | Chro.20464 | thioredoxin reductase |
Cryptosporidium parvum | cgd2_4320 | thioredoxin reductase 1 |
Dictyostelium discoideum | DDB_G0272754 | glutathione reductase |
Drosophila melanogaster | Dmel_CG11401 | thioredoxin reductase 2 |
Drosophila melanogaster | Dmel_CG2151 | Thioredoxin reductase-1 |
Escherichia coli | b3500 | glutathione oxidoreductase |
Echinococcus granulosus | EgrG_000222300 | thioredoxin glutathione reductase |
Echinococcus multilocularis | EmuJ_000222300 | thioredoxin glutathione reductase |
Homo sapiens | ENSG00000197763 | thioredoxin reductase 3 |
Homo sapiens | ENSG00000104687 | glutathione reductase |
Homo sapiens | ENSG00000198431 | thioredoxin reductase 1 |
Homo sapiens | ENSG00000184470 | thioredoxin reductase 2 |
Leishmania braziliensis | LbrM.05.0350 | trypanothione reductase |
Leishmania donovani | LdBPK_050350.1 | trypanothione reductase |
Leishmania infantum | LinJ.05.0350 | trypanothione reductase |
Leishmania major | LmjF.05.0350 | trypanothione reductase |
Leishmania mexicana | LmxM.05.0350 | trypanothione reductase |
Loa Loa (eye worm) | LOAG_01116 | glutathione reductase |
Loa Loa (eye worm) | LOAG_02317 | thioredoxin reductase |
Mus musculus | ENSMUSG00000031584 | glutathione reductase |
Mus musculus | ENSMUSG00000075704 | thioredoxin reductase 2 |
Mus musculus | ENSMUSG00000020250 | thioredoxin reductase 1 |
Mus musculus | ENSMUSG00000000811 | thioredoxin reductase 3 |
Mycobacterium tuberculosis | Rv2855 | NADPH-dependent mycothiol reductase Mtr |
Neospora caninum | NCLIV_053860 | MGC84926 protein, related |
Neospora caninum | NCLIV_063590 | Glutathione reductase, related |
Oryza sativa | 9270365 | Os10g0415112 |
Oryza sativa | 4331112 | Os02g0813500 |
Oryza sativa | 4348623 | Os10g0415300 |
Oryza sativa | 4331719 | Os03g0163300 |
Plasmodium berghei | PBANKA_0824700 | thioredoxin reductase, putative |
Plasmodium berghei | PBANKA_1023400 | glutathione reductase, putative |
Plasmodium falciparum | PF3D7_0923800 | thioredoxin reductase |
Plasmodium falciparum | PF3D7_1419800 | glutathione reductase |
Plasmodium knowlesi | PKNH_0721800 | thioredoxin reductase, putative |
Plasmodium knowlesi | PKNH_1338200 | glutathione reductase, putative |
Plasmodium vivax | PVX_099600 | thioredoxin reductase, putative |
Plasmodium vivax | PVX_085490 | glutathione reductase, putative |
Plasmodium yoelii | PY01204 | glutathione reductase |
Plasmodium yoelii | PY02397 | thioredoxin reductase |
Saccharomyces cerevisiae | YPL091W | glutathione-disulfide reductase GLR1 |
Schistosoma japonicum | Sjp_0021180 | ko:K00384 thioredoxin reductase (NADPH) [EC1.8.1.9], putative |
Schmidtea mediterranea | mk4.000203.07 | Probable glutathione reductase 2 |
Schmidtea mediterranea | mk4.000203.06 | |
Schmidtea mediterranea | mk4.001663.03 | |
Trypanosoma brucei gambiense | Tbg972.10.12680 | trypanothione reductase, putative |
Trypanosoma brucei | Tb927.10.10390 | trypanothione reductase |
Trypanosoma congolense | TcIL3000_10_8870 | trypanothione reductase, putative |
Trypanosoma cruzi | TcCLB.503555.30 | trypanothione reductase, putative |
Toxoplasma gondii | TGME49_309730 | thioredoxin reductase |
Theileria parva | TP03_0110 | thioredoxin reductase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2902 | Mycobacterium tuberculosis | essential | nmpdr |
Tb927.10.10390 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.10390 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.10390 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.10390 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3500 | Escherichia coli | non-essential | goodall |
PBANKA_1023400 | Plasmodium berghei | Dispensable | plasmo |
TGME49_309730 | Toxoplasma gondii | Essentiality uncertain | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 510 aa | 20.5% | 521 aa | Compounds | References |
Trypanosoma cruzi | trypanothione reductase, putative | 189 aa | 35.3% | 201 aa | Compounds | References |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 550 aa | 19.3% | 538 aa | Compounds | References |
Mycobacterium tuberculosis | Probable thioredoxin reductase TrxB2 (TRXR) (TR) | 335 aa | 19.7% | 366 aa | Compounds | References |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 510 aa | 20.5% | 521 aa | Compounds | References |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 550 aa | 19.1% | 551 aa | Compounds | References |